No Data
No Data
Boundless Bio's Q3 2024: Advancing Cancer Therapies
Express News | Boundless Bio Q3 2024 GAAP EPS $(0.74) Beats $(0.82) Estimate
Express News | Boundless Bio Inc Q3 Shr View $-0.75 -- LSEG IBES Data
Boundless Bio | 10-Q: Q3 2024 Earnings Report
Boundless Bio | 8-K: Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
Express News | Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
No Data
No Data